DXI Capital Corp. Announces Proposed Acquisition of V.V.T. Med Ltd. and Exiteam Acquisition Corp.

DXI Capital Corp. is pleased to announce that it has entered into a non-binding letter of intent dated November 22, 2023 with V.V.T. Med Ltd. , an Israeli corporation, and Exiteam Acquisition Corp....

Related Keywords

Hebrew University ,Yerushalayim ,Israel ,Hong Kong ,France ,New Zealand ,Austria ,Ukraine ,Cyprus ,Kfar Saba ,Hamerkaz ,Brazil ,Germany ,United States ,South Korea ,Canada ,Australia ,United Kingdom ,Vancouver ,British Columbia ,Italy ,Chile ,India ,Israeli ,Ukrainian ,State Of Israel ,Canadian ,British ,Zeev Brandeis ,Yacov Reizman ,Erez Tetro ,Yacov Machover ,Ralf Kolvenbach ,Eitan Machover ,Robertl Hodgkinson ,Yair Aloni ,Haim Maimon ,Ilan University ,British Columbia Newsfile Corp ,V Vt Med Ltd ,Exiteam Acquisition Corp ,Covidien Israel Holding ,Venture Exchange ,Capital Corp ,Exchange Ratio ,Regulation Services Provider ,Bonds ,Exiteam Acquisition ,Proposed Transaction ,Vascular Surgery ,Inverse Action Dual Syringe ,Double Lumen ,Universal Platform ,Chronic Venous Insufficiency ,Great Saphenous Vein ,Cyprus Chez ,Ended December ,Medtronic Israel ,Due Diligence ,Resulting Issuer Share ,Issuer Shares ,Resulting Issuer Shares ,Concurrent Debt Settlement ,Transaction Price ,Resulting Issuer ,Georgia Street ,Subscription Receipt ,Each Unit Warrant ,Multi Lateral Instrument ,Minority Security Holders ,Name Change ,United States Securities Act ,Markets ,